Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Neuroscience Letters|March 8, 2000
CPI-1189 inhibits interleukin 1beta-induced p38-mitogen-activated protein kinase phosphorylation: an explanation for its neuroprotective properties?K Hensley, K A Robinson, Q N Pye, et al.Journal of the Neurological Sciences|July 1, 1990
The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's diseaseB R Bloem, I Irwin, O J Buruma, et al.European Journal of Pharmacology|September 4, 1990
Modulating role of dopamine on anesthetic requirementsI S Segal, J K Walton, I Irwin, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
Effects of benzoyltropine and tropacocaine on several cholinergic processes in the rat brainE M Meyer, L T Potter, C L De Vane, et al.Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.JAMA|July 1, 1988
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primatesG A Ricaurte, L S Forno, M A Wilson, et al.Brain Research|October 28, 1996
Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeysD A Di Monte, L E DeLanney, I Irwin, et al.Life Sciences|March 18, 1985
New amphibian models for the study of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)A Barbeau, L Dallaire, N T Buu, et al.Pharmaceutical Research|November 1, 1993
Origin of the isoelectric heterogeneity of monoclonal immunoglobulin h1B4P K Tsai, M W Bruner, J I Irwin, et al.Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|December 1, 1994
Aging and the nigrostriatal dopamine system: a non-human primate studyI Irwin, L E DeLanney, T McNeill, et al.Pageof 8